Treatment of Paraphilic Sexual Offenders in Brazil: Issues and Controversies

Abstract

Psychopharmacological treatments have not only proven to be valuable but sometimes indispensable in the management of paraphilic sexual offenders. Despite not being approved by the FDA, some medications commonly used in paraphilic outpatients, such as Medroxyprogesterone and Leuprolide Acetate, cannot be considered an experimental or investigative medical procedure. Unfortunately, in Brazil, the use of hormonal medications for the treatment of dangerous sexual offenders has been seen as amoral and insufficiently effective and safe. This position creates many difficulties in the adequate management of sexual offenders in our country.